Skip to content
10-Q

Quarterly Report

Galileo Life Sciences, Inc.

0001471242-14-000260

← back to feed
Filed
Jun 26, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2014 · Jun 24, 2014 75.48M sh
Operating Cash Flow Q1 2014 · Sep 30, 2013 −$474
Operating Cash Flow Q1 2014 · Sep 30, 2013 −$430.67K
Operating Cash Flow Q1 2014 · Sep 30, 2012 −$3.2K
Stockholders Equity Q1 2014 · Sep 30, 2013 −$530.55K
Stockholders Equity Q1 2014 · Jun 30, 2013 −$519.77K
Current Liabilities Q1 2014 · Sep 30, 2013 $530.55K
Current Liabilities Q1 2014 · Jun 30, 2013 $519.77K
Total Liabilities Q1 2014 · Sep 30, 2013 $530.55K
Total Liabilities Q1 2014 · Jun 30, 2013 $519.77K
Total Assets Q1 2014 · Sep 30, 2013 $0
Total Assets Q1 2014 · Jun 30, 2013 $0
Net Income Q1 2014 · Sep 30, 2013 −$10.78K
Net Income Q1 2014 · Sep 30, 2013 −$595.82K
Operating Income Q1 2014 · Sep 30, 2013 −$9.01K
Operating Income Q1 2014 · Sep 30, 2013 −$596.66K
Gross Profit Q1 2014 · Sep 30, 2013 $3.41K
Cost Of Revenue Q1 2014 · Sep 30, 2013 $6.1K
Revenue Q1 2014 · Sep 30, 2013 $9.51K